Listeria Monocytogenes

Shmuel Shoham, M.D., John G. Bartlett, M.D.

MICROBIOLOGY

  • Small Gram-positive rod, non-spore forming.
  • Listeria serotypes are designated by their O and H antigens.
    • Sero-types 1/2a, 1/2b, and 4b cause almost all human infections and serotype 4b is associated with outbreaks.
  • Isolated from environmental sources such as water, sewerage and foodstuffs.
  • Listeria possesses multiple characteristics that allow it to adapt to environmental stresses and survive disinfection:
    • Ability to grow at wide range of environmental conditions (e.g., temperatures as low as 2°C, NaCl concentration as high as 10%, pH of 4.5).
    • Some strains are resistant to biocides.
    • Organism can form biofilm, which facilitate survival in the environment.
  • Grows on routine media.
    • Micro labs may occasionally confuse as a contaminant, reporting organisms as diphtheroids.
  • Main human pathogen: Listeria monocytogenes.
    • Other: L. ivanovii (rare)
  • Ability to grow well at 4–10°C likely accounts for organism surviving in refrigerated foods and subsequently leading to infection

CLINICAL

  • Two major clinical syndromes:
    • Gastroenteritis: mild, non-invasive and generally self limiting.
    • Listeriosis: Severe, invasive illness with mortality rate ~20%. Typical manifestations include fetal loss in pregnant women, CNS disease, bloodstream infections.
      • Risk factors:
        • Extremes of age (e.g., < 1 month and > 65 yrs)
        • Pregnancy
          • In US risk especially high in Latin American women.
        • Immunocompromised state (e.g., hematologic malignancy, HIV, organ transplant, corticosteroid use, immunosuppressants, chronic liver disease, ESRD, heavy alcohol, auto-immune disease)
  • Most cases are NOT linked to outbreaks of listeriosis.
  • Outbreaks: most common with ready to eat food:
    • Examples; milk (especially unpasteurized), high fat dairy products, soft cheeses (especially Latin-style soft cheeses), smoked fish, ready-to-eat shrimp and crab, hot dogs, deli- type salads and meats, fresh-cut fruits and vegetables and unwashed raw produce
  • Dx:
    • Culture from normally sterile site (CSF, blood, etc).
    • CSF PCR might be useful as adjunct for evaluation of CNS disease
    • Stool culture: Low sensitivity and ~5% of people may have + fecal carriage without infection.
      • Not recommended for diagnosis
    • Serologic testing: poor sensitivity and specificity.
      • Not recommended for diagnosis of listeriosis in individual patients.
      • Useful for epidemiological investigations, though increasingly, this is being done by genotyping.
  • Outcomes with invasive disease
    • Pregnancy: ~20-25% have fetal loss (especially before 29 weeks)
    • CNS infection: ~30% mortality
    • Bloodstream infection:~45% mortality

SITES OF INFECTION

  • CNS: Listeria accounts for ~2% of neonatal and ~4% of adult bacterial meningitis cases
    • Presents with encephalitic symptoms (87%), nuchal rigidity (65%) aphasia (19%), seizures (18%), brainstem abnormalities (17%).
      • Less commonly as focal neurological signs, CN abnormalities
    • Diagnosis: positive CSF Gram stain ~30%, CSF culture ~85%, CSF PCR ~60%, BCx +63%
    • Manifestations:
      • Meningoencephalitis (~87%)
      • Meningitis alone (~13%)
      • Brainstem encephalitis/rhomboencephalitis (~17%)
      • Other presentations: Brain abscess, cranial nerve deficits, cerebellar signs, and/or hemiparesis.
  • Bacteremia especially elderly adults, pregnant women, neonatal sepsis: Mortality rate ~45%
  • Pregnancy:
    • Diagnosis: maternal Blood cultures (~ 55%), placental cultures (~80%), newborn gastric cultures: (~ 80%)
    • Manifestations: Fevers, obstetric signs (contractions, abnormal fetal heart rate, labor), fetal loss (~20-25%), pre-term birth (~45%)
    • Bloodstream infections >> meningitis in this population.
  • Gastroenteritis: fever, diarrhea, joint pains; usually in outbreaks from contaminated foods
  • Focal infections (rare): Peritonitis, bones and joints, pleural, cardiac, UTI, pneumonia, biliary, adenitis, conjunctivitis

TREATMENT

Infections

  • Meningitis
    • Preferred (all doses listed are for adults with normal renal function)
      • Ampicillin 2gm IV q4-6h (or penicillin G 4 MU IV q4h)+ gentamicin 1.7mg/kg IV q8h x ≥ 3wks.
        • Monitor renal function closely with gentamicin. May stop after 1-2 weeks if patient is significantly improved and/or renal function declines.
      • AVOID dexamethasone: Associated with worse outcomes[1].
        • If started as empiric therapy and patient found to have Listeria- stop dexamethasone.
    • Alternatives:
    • Not active/clinical failures associated with cephalosporins, vancomcyin, quinolones, tetracyclines. DO NOT USE.
  • Bacteremia (without meningitis): use meningitis options x 2wks, unless immunocompromised, in which case longer therapy may be necessary.
  • Brain abscess, rhomboencephalitis or cerebritis: use meningitis options x 4-6 wks or longer,
  • Gastroenteritis: as stool not typically cultured for this organism, most often not diagnosed and usually no antibiotic treatment.

General Prevention Measures

  • Thoroughly cook animal source food
  • Thoroughly wash raw vegetables
  • Avoid unpasteurized milk and food from unpasteurized milk
    • Also, smoked seafood, meat spreads, pâtés, cold cuts, hot dogs
  • Wash hands, utensils and cutting boards used with uncooked food
  • Keep ready-to-eat food cold
  • Person-to-person transmission is not a risk (except pregnant woman to unborn infant)

Prevention: High Risk Persons

  • High-risk groups: pregnant women, CMI compromise (organ transplants, chronic steroids, infliximab or other TNF-antagonists, cancer chemotherapy, elderly.
    • Avoid soft cheeses: Mexican style, feta, brie, Camembert, blue cheese
    • Leftover foods and ready-to-eat foods should served only steaming hot
    • May wish to avoid food from delicatessen counters
  • Pregnancy: for those known to have been exposed to Listeria, recommendations based largely on expert opinion (ACOG 2014[3])
    • 13x higher risk for developing listeriosis than general population
    • Recommendations based on state of pregnant patient:
      • Asymptomatic: no testing or treatment. Instruct to report sx of fever, GI disease, etc. within next 2 months as at risk.
      • Mild symptoms, afebrile: no data to guide
        • Perform blood culture OR
        • Follow expectantly including fetal well-being--testing if symptoms worsen
        • Treatment: no clear consensus, either observe pending test results or begin empiric therapy (IV ampicillin)
      • Fever (T > 38.1°C /100.6°F with our without symptoms consistent with listeriosis
        • Perform simultaneous testing and treatment (IV ampicillin)
        • Test: blood, placental cultures (if delivery occurs)
  • TMP/SMX given to HIV infected patients to prevent PCP is thought to reduce Listeria risk
  • Routine stool culture for assessment: not recommended as may be frequently seen with fecal carriage/shedding without causing illness

Selected Drug Comments

Drug

Recommendation

Ampicillin

The drug of choice by virtually all authorities in the field - based on in vitro data, animal models and a small clinical experience. The evidence that it is superior to penicillin is not convincing. The evidence that it is better than cephalosporins is very convincing. Ampicillin is allegedly bacteriostatic to Listeria and this is the reason many advocate the addition of an aminoglycoside. IV amoxicillin available outside of US and used in place of ampicillin

Cefotaxime

Cephalosporins do not have activity against Listeria. This is important to remember in the empiric selection of drugs for pyogenic meningitis.

Ceftriaxone

Ceftriaxone/cefotaxime. Cephalosporins do not have activity against Listeria. This is important to remember in the empiric selection of drugs for pyogenic meningitis.

Gentamicin

Often added to ampicillin to achieve synergy. It is not clear that this is necessary.

Rifampin

Good in vitro activity, but very limited clinical experience and dangerous for monotherapy of any infection. OK to add.

Trimethoprim/sulfamethoxazole

TMP/SMX The preferred drug in patients who cannot take ampicillin. This combination has good in vitro activity and is bactericidal vs Listeria.

Vancomycin

There are clinical successes; there are also patients who developed Listeria meningitis while receiving vancomycin.

OTHER INFORMATION

  • Although part of its name, human monocytosis uncommon--seen in experimental animal studies in rabbits.

Basis for recommendation

  1. Charlier C et al: Clinical features and prognostic factors of listeriosis: the MONALISA national prospective cohort study. Lancet Infect Dis 17:510, 2017  [PMID:28139432]

    Comment: Large prospective study of invasive listeriosis in France. Detailed picture of clinical manifestations and outcomes provided in this important study. Evidence provided that dexamethasone is associated with worse outcomes

  2. van de Beek D et al: ESCMID guideline: diagnosis and treatment of acute bacterial meningitis. Clin Microbiol Infect 22 Suppl 3:S37, 2016  [PMID:27062097]

    Comment: Updated guidelines on bacterial meningitis that include etiologies of CNS infection (including Listeria) in different age groups and provide treatment recommendations.

  3. Committee on Obstetric Practice, American College of Obstetricians and Gynecologists: Committee Opinion No. 614: Management of pregnant women with presumptive exposure to Listeria monocytogenes. Obstet Gynecol 124:1241, 2014  [PMID:25411758]

    Comment: Recommendations regarding pregnant women who are exposed to Listeria. Presumptive testing and treatment recommended.

  4. Tunkel AR et al: Practice guidelines for the management of bacterial meningitis. Clin Infect Dis 39:1267, 2004  [PMID:15494903]

    Comment: IDSA Guidelines for meningitis: For L. monocytogenesmeningitis - preferred is Penicillin G or ampicillin (consider adding gentamicin ). Alternatives are TMP-SMX or meropenem . Doses: Amp - 12gm/d, gent 5mg/kg/d, TMP-SMX 10-20mg/kg (TMP)/d.

  5. Rados C: Preventing Listeria contamination in foods. FDA Consum 38:10, 2004 Jan-Feb  [PMID:15032197]

    Comment: Keep ready-to-eat food cold

References

  1. Jackson KA et al: Listeriosis Outbreaks Associated with Soft Cheeses, United States, 1998-20141. Emerg Infect Dis 24:1116, 2018  [PMID:29774843]

    Comment: Report of multiple outbreaks of listeriosis associated with consumption of soft cheeses. Highest risk are Latin-style cheeses.

  2. Bergholz TM et al: Genomic and phenotypic diversity of Listeria monocytogenes clonal complexes associated with human listeriosis. Appl Microbiol Biotechnol 102:3475, 2018  [PMID:29500754]

    Comment: Review of mechanisms by which Listeria is able to adapt to a range of environmental conditions, and the impact that this adapatibiity has upon acquisition of infection in humans

  3. Lim S et al: Predictive risk factors for Listeria monocytogenes meningitis compared to pneumococcal meningitis: a multicenter case-control study. Infection 45:67, 2017  [PMID:27541039]

    Comment: This study compared risk factors for Listeria meningitis with those for peumococcal meningitis. Reciept of an immunosuppressive agent and liver disease where independently associated with listeriosis.

  4. Fox EM, Wall PG, Fanning S: Control of Listeria species food safety at a poultry food production facility. Food Microbiol 51:81, 2015  [PMID:26187831]

    Comment: Pulsed-field gel electrophoresis was used to facilitate control of Listeria in a food production facility.

  5. Heiman KE et al: Multistate outbreak of listeriosis caused by imported cheese and evidence of cross-contamination of other cheeses, USA, 2012. Epidemiol Infect Jun 30  [PMID:26122394]

    Comment: Outbreak of listeriosis from contaminated cheese from multiple sources. Molecular analysis connected multiple cheese sources possibly due to cross-contamination.

  6. Girard D et al: Pregnancy-related listeriosis in France, 1984 to 2011, with a focus on 606 cases from 1999 to 2011. Euro Surveill 19:, 2014  [PMID:25306879]

    Comment: The review from France includes listerosis in 606 listeria infections. Outcome showed fetal loss in 27% and live-born neonatal listerosis in 58%, and premature birth in 14%.

  7. Bodro M, Paterson DL: Listeriosis in patients receiving biologic therapies. Eur J Clin Microbiol Infect Dis 32:1225, 2013  [PMID:23568606]

    Comment: Major risk was infliximab based on FDA records showing 266 cases of listeriosis in patients getting biologies. Mortality rates: 11-27%.
    Rating: Important

  8. Centers for Disease Control and Prevention (CDC): Vital signs: Listeria illnesses, deaths, and outbreaks--United States, 2009-2011. MMWR Morb Mortal Wkly Rep 62:448, 2013  [PMID:23739339]

    Comment: Review of reported listeria to the CDC for 2009-2011 (n=1,651) 14% pregnant, 74% had immunosuppression from malignancy or treatment. Soft cheese was the most common source.
    Rating: Important

  9. Goulet V et al: Incidence of listeriosis and related mortality among groups at risk of acquiring listeriosis. Clin Infect Dis 54:652, 2012  [PMID:22157172]

    Comment: The review was 1959 cases of listerosis in France from 2001-2008. Risk was >1000 fold with chronic lymphocytic leukemia; risk was 100-1000 fold with liver cancer, myeloma, acute leukemia, giant cell arteritis, organ transplantation and pregnancy.

  10. Charlier C et al: Listeria monocytogenes-associated joint and bone infections: a study of 43 consecutive cases. Clin Infect Dis 54:240, 2012  [PMID:22100574]

    Comment: Authors review 43 cases of L. monocytogenes bone and joint infections. The most common treatment was amoxicillin (80%) with aminoglycosides (48%) for a median of 15 weeks. Prosthetic joints accounted for 36 (84%) at a median of 9 years post insertion.

  11. Kupferschmidt K: Epidemiology. Outbreak detectives embrace the genome era. Science 333:1818, 2011  [PMID:21960605]

    Comment: Review of gene sequence during outbreak investigation.
    Rating: Important

  12. Varma JK et al: Listeria monocytogenes infection from foods prepared in a commercial establishment: a case-control study of potential sources of sporadic illness in the United States. Clin Infect Dis 44:521, 2007  [PMID:17243054]

    Comment: CDC review of non-outbreak cases in 249 patients. New food sources -- melons and hummus.
    Rating: Important

  13. Brouwer MC et al: Community-acquired Listeria monocytogenes meningitis in adults. Clin Infect Dis 43:1233, 2006  [PMID:17051485]

    Comment: Review of 30 cases of Listeria meningitis - all were immunocompromised or >50yrs. Gram stain of CSF was pos in 7/25 (28%), Mortality 5/30 (17%).
    Rating: Important

  14. Schlech WF et al: Does sporadic Listeria gastroenteritis exist? A 2-year population-based survey in Nova Scotia, Canada. Clin Infect Dis 41:778, 2005  [PMID:16107973]

    Comment: Review 7,775 stools submitted for culture - 17 yielded L. monocytogenes. PFGE showed no clusters. Cases tended to have pre-existing GI conditions. Recommendation is to not culture stool for Listeria.

  15. Ooi ST, Lorber B: Gastroenteritis due to Listeria monocytogenes. Clin Infect Dis 40:1327, 2005  [PMID:15825036]

    Comment: Review of 7 outbreaks of foodborne gastroenteritis due to L. monocytogenes . Symptoms occur 24 hrs after ingestion of large inoculum with fever, watery diarrhea, nausea, headache and arthralgias. Most cases clear within 2 days and don't require antibiotics; consider ampicillin or TMP-SMX in susceptible hosts.

  16. Van Kessel JS et al: Prevalence of Salmonellae, Listeria monocytogenes, and fecal coliforms in bulk tank milk on US dairies. J Dairy Sci 87:2822, 2004  [PMID:15375040]

    Comment: Analysis of 861 bulk tank milk from 21 states showed Listeria in 56 (6.5%); of these 93% were serotypes commonly found in human disease.

  17. Lecuit M et al: A transgenic model for listeriosis: role of internalin in crossing the intestinal barrier. Science 292:1722, 2001  [PMID:11387478]

    Comment: The authors describe A NEW VIRULENCE FACTOR for L. monocytogenes - a surface protein that binds to E - cadherin of enterocytes which is a necessary step for translocation.

  18. Dalton CB et al: An outbreak of gastroenteritis and fever due to Listeria monocytogenes in milk. N Engl J Med 336:100, 1997  [PMID:8988887]

    Comment: Outbreak of L. monocytogenes as cause of FOODBORNE OUTBREAK among 60 attendees at a Holstein cow show ascribed to post-pasteurization contamination of chocolate milk. Attack rate was 75%; symptoms were diarrhea 79%, fever 72% and chills 65%. The median incubation period was 20hrs and median duration of diarrhea 42hrs. Contamination level was up to 3x10" bacteria/person.

  19. Armstrong RW, Fung PC: Brainstem encephalitis (rhombencephalitis) due to Listeria monocytogenes: case report and review. Clin Infect Dis 16:689, 1993  [PMID:8507761]

    Comment: This is a BRAINSTEM ENCEPHALITIS which is an unusual CNS complication of Listeria that occurs in previously healthy adults. It is analogous to "circling disease" in sheep. Clinical features are biphasic: fever, headache, nausea & vomiting, lasting several days and then cerebellar signs: cranial nerve deficits & hemiparesis. CSF shows increased protein & WBC; culture is positive in 50%. MRI shows rhomboencephalitis.

  20. Durand ML et al: Acute bacterial meningitis in adults. A review of 493 episodes. N Engl J Med 328:21, 1993  [PMID:8416268]

    Comment: This review showed L. monocytogenes accounted for 29 (11%) of 253 cases of community-acquired MENINGITIS and had a mortality rate of 21%.

  21. Kalstone C: Successful antepartum treatment of listeriosis. Am J Obstet Gynecol 164:57, 1991  [PMID:1986626]

    Comment: Infection in PREGNANCY usually occurs in 3rd trimester, 22% result in stillbirth, susceptibility presumed to be due to compromised CMI of pregnancy, maternal meningitis is rare & early therapy is often effective in protecting the infant.

  22. Gallagher PG, Watanakunakorn C: Listeria monocytogenes endocarditis: a review of the literature 1950-1986. Scand J Infect Dis 20:359, 1988  [PMID:3057615]

    Comment: Listeria accounts for about 7% of ENDOCARDITIS cases in adults, usually in patients with pre-existing valve disease. The mortality rate in this review was 48%.

Listeria Monocytogenes is a sample topic from the Johns Hopkins ABX Guide.

To view other topics, please or purchase a subscription.

Official website of the Johns Hopkins Antibiotic (ABX), HIV, Diabetes, and Psychiatry Guides, powered by Unbound Medicine. Johns Hopkins Guide App for iOS, iPhone, iPad, and Android included. Learn more.

Last updated: October 2, 2018

Citation

* When formatting your citation, note that all book, journal, and database titles should be italicized* Article titles in AMA citation format should be in sentence-case
TY - ELEC T1 - Listeria Monocytogenes ID - 540318 A1 - Shoham,Shmuel,M.D. AU - Bartlett,John,M.D. Y1 - 2018/10/02/ PB - Johns Hopkins ABX Guide UR - https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540318/all/Listeria_Monocytogenes ER -